Companies: 10,795·Total market cap: $144.5T

Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.

TCRTNASDAQHealthcare● Active

$2.05

$-0.24(-10.31%)

Market Cap$4994189

P/E Ratio—

52W High$6.2

52W Low$1.67

Avg Volume16K

Open$2.33

Beta-1.06

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Alaunos Therapeutics, Inc.（TCRT）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · TCRT · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.17Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)3000.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding1.9MShares outstanding history

Next EarningsAug 18, 2026Est.Earnings history

探索 Alaunos Therapeutics, Inc. 数据

分析师预测$— · Hold

股息不分红

营收$5000-50.00%

盈利EPS $-2.20+24.66%

财务快照

FY 2025Revenue$5000.00▼ 50.00% YoY

202320242025

FY 2025Net Income-$4.2M▲ +10.75% YoY

202320242025

FY 2025EPS$-2.20▲ +24.66% YoY

202320242025

TTM:Revenue: $3000.00Net Income: -$4.1MEPS: $-2.17View income statement →

分析师评级与目标价

Hold10 位分析师

Strong Buy

0

Buy

1

Hold

8

Sell

1

Strong Sell

0

12-Month Price Target

$—Low

$2.04Current

$—Avg Target

$—High

合计: 10 · 买入占比: 10.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Alaunos Therapeutics, Inc.

$2.05-10.31%$5.0M #2

Addex Therapeutics Ltd

$6.40+17.75%$4.6M #3

AIM ImmunoTech Inc.

$0.52+0.43%$1.8M #4

Cyclerion Therapeutics, Inc.

$3.00+0.67%$13.0M #5

Impact BioMedical Inc.

$0.56-1.87%$7.0M #6

Pasithea Therapeutics Corp.

$0.58-1.21%$4.3M

股票表现

1D-10.96%

1W-28.52%

1M-21.32%

3M-43.77%

YTD-37.15%

1Y-34.94%

5Y-99.54%

关于 Alaunos Therapeutics, Inc.

CEOHolger Weis

IPO DateAug 24, 2005

Employees1

CountryUS

Websitealaunos.com

Alaunos Therapeutics, Inc. a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial fo…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Alaunos Therapeutics, Inc.（TCRT）是 Biotechnology 行业的 Healthcare 类公司，于 Aug 24, 2005 在 NASDAQ 上市。截至最近交易日，TCRT 股价为 $2.04，市值约为 $5.0M。过去12个月累计回报 -34.94%，年初至今回报 -37.15%。

根据 10 位华尔街分析师，Alaunos Therapeutics, Inc. 股票共识评级为Hold，12个月平均目标价为 $—。2025 财年 Alaunos Therapeutics, Inc. 营收 $5000.00，净利润 -$4.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Alaunos Therapeutics, Inc.（TCRT）股价为 $2.04，在 NASDAQ 上市，52周区间为 $1.67 – $6.20。

TCRT 最新股价TCRT quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议